January 30, 2012 at 16:44 PM EST
Markets Close Lower Over Greek Debt Concerns

The markets recovered earlier losses in afternoon trading but ended the session lower with the Dow slipping 6 points to 12,653 as the Greek debt crisis continued to weigh on investors. Nasdaq lost 4 points to 2811.

On the upside

Citigroup expects GTx (Nasdaq: GTXI) to report positive results next year for a Phase III clinical trial of its cancer related muscle wasting treatment Ostarine and lifted its price target on the biopharmaceutical to $19 per share.


Comstock Resources (NYSE: CRK) reported a 25% increase in proved oil and natural gas reserves last year.

Shares of InvenSense (NYSE: INVN) continued rising after posting sharply higher third quarter earnings last week that surpassed analyst expectations by a wide margin.


On the downside


Hyperdynamics (NYSE: HDY) will raise approximately $30 million through a registered direct offering.


The Food and Drug Administration approved the skin cancer treatment Erivedge which is made by Curis (Nasdaq: CRIS) and Genentech but the stock price fell.

Globe Specialty Metals (NYSE: GSM) warned of lower second quarter earnings.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 2 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 6 points to 792.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here